Want to see SBEV full AI Analyst Report?
Top Page
Splash Beverage Group
(NYSE MKT:SBEV)
Select Model
Select Model
Rating:43Neutral
Price Target:
$0.41
â–¼(-43.84% Downside)
Action:Reiterated
Date:08/21/26
The score is driven primarily by very weak financial performance (collapsed revenues, large ongoing losses, negative equity, and continued cash burn). Technicals also weigh on the rating given the longer-term downtrend and negative MACD, while corporate events provide only partial offset via restructuring and a strategic pivot amid continued listing/compliance and funding risks.
Positive Factors
CannEpil Licensing and Pipeline
The CannEpil license adds an established cannabinoid pharmaceutical asset and international regulatory experience, broadening the company beyond beverages. Existing market access and an FDA IND provide a foundation for longer-term development, although further approvals remain necessary.
Negative Factors
Severe Revenue Deterioration
The collapse in reported sales indicates major disruption in the legacy operating model and leaves little revenue base to fund development. Rebuilding commercial scale will require successful products, distribution and execution while the company pursues its strategic transformation.
Read all positive and negative factors
Positive Factors
Negative Factors
CannEpil Licensing and Pipeline
The CannEpil license adds an established cannabinoid pharmaceutical asset and international regulatory experience, broadening the company beyond beverages. Existing market access and an FDA IND provide a foundation for longer-term development, although further approvals remain necessary.
Read all positive factors
Splash Beverage Group (SBEV) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$3.02M
Dividend YieldN/A
Average Volume (3M)3.65M
Price to Earnings (P/E)―
Beta (1Y)1.73
Revenue Growth-83.63%
EPS Growth65.38%
CountryUS
Employees2
SectorConsumer Defensive
Sector Strength42
IndustryBeverages - Wineries & Distilleries
Share Statistics
EPS (TTM)-26.79
Shares Outstanding6,412,521
10 Day Avg. Volume5,591,683
30 Day Avg. Volume3,647,912
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.10
Price to Sales (P/S)20.57
P/FCF Ratio-0.31
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue>-0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-52.8
Revenue Forecast (FY)$17.89M
Splash Beverage Group Business Overview & Revenue Model
Company Description
Based in Fort Lauderdale, Florida, Splash Beverage Group, Inc. operates within the U.S. beverage market, focusing on the production, distribution, promotion, and retail of a diverse selection of drinks. Their product portfolio features SALT Natura...
How the Company Makes Money
Splash Beverage Group primarily makes money by selling packaged beverage products under its brand portfolio into wholesale and retail channels. Revenue is generally generated when products are shipped/sold to distributors, retailers, or other chan...
Splash Beverage Group Earnings Call Summary
Earnings Call Date:Nov 25, 2024
(Q3-2024)
| % Change Since: |
Next Earnings Date:Nov 18, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted significant improvements in gross margins and distribution expansion, along with substantial capital raising efforts and promising acquisition opportunities. However, persistent liquidity challenges and legal issues with ABG TapouT, coupled with a notable net loss, underscore ongoing financial hurdles.Positive Updates
Improved Gross Margins
Q3 2024 gross margins increased to 30%, up from 23% in Q2 2024 and 11% in Q1 2024, driven by strategic sourcing and lower wine costs.
Negative Updates
Liquidity Challenges
Ongoing liquidity issues impacting inventory and sales, with net sales of $381,000 in Q3 2024, down from over $1 million in Q2 2024.
Read all updates
Q3-2024 Updates
Positive
Negative
Improved Gross Margins
Q3 2024 gross margins increased to 30%, up from 23% in Q2 2024 and 11% in Q1 2024, driven by strategic sourcing and lower wine costs.
Read all positive updates
Company Guidance
During the Q3 2024 earnings call for Splash Beverage Group, CEO Robert Nistico provided comprehensive guidance on the company's financial and strategic outlook. Key highlights included a significant improvement in gross margins, which rose to 30% from 23% in Q2 and 11% in Q1, driven by strategic sourcing programs and a reduction in SG&A expenses by $500,000 from the previous quarter. Despite liquidity challenges, the company managed to raise approximately $8 million since August 2024 to support working capital and potential acquisitions. CFO Julius Ivancsits reported Q3 net sales of $381,000, a slight decline from Q2, attributed to inventory limitations. However, the gross margin saw an increase of $244,000 from Q2, reaching $981,000 in Q3, supported by the restart of the Qplash resale business, which boasts a gross margin of 59%. Operating expenses decreased by $1 million, contributing to an improved EBITDA loss of $1.7 million, a $2 million improvement from Q3 2023. The company's liquidity remained tight, with a cash balance of $457,000 at the end of Q3. Looking forward, Splash anticipates positive cash flow and EBITDA by Q3 2025, bolstered by distribution expansions and strategic acquisitions, including an energy drink company with projected growth of over 30%.Splash Beverage Group Financial Statement Overview
Summary
Income Statement
6
Very Negative
Balance Sheet
8
Very Negative
Cash Flow
7
Very Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -360.98K | 73.07K | 4.16M | 18.85M | 18.09M | 11.32M |
| Gross Profit | -632.71K | 16.90K | 355.45K | 5.57M | 5.92M | 2.58M |
| EBITDA | -13.60M | -19.97M | -15.84M | -14.76M | -20.45M | -28.67M |
| Net Income | -17.28M | -25.23M | -23.76M | -21.00M | -21.84M | -29.05M |
Balance Sheet | ||||||
| Total Assets | 1.08M | 965.69K | 2.76M | 9.90M | 17.30M | 16.39M |
| Cash, Cash Equivalents and Short-Term Investments | 242.70K | 281.44K | 15.35K | 379.98K | 4.43M | 4.18M |
| Total Debt | 6.39M | 6.67M | 12.55M | 9.35M | 4.37M | 5.04M |
| Total Liabilities | 16.83M | 16.27M | 21.39M | 15.50M | 7.98M | 7.51M |
| Stockholders Equity | -15.75M | -15.30M | -18.63M | -5.61M | 9.32M | 8.87M |
Cash Flow | ||||||
| Free Cash Flow | -6.20M | -4.79M | -8.01M | -10.20M | -14.20M | -15.13M |
| Operating Cash Flow | -5.41M | -4.79M | -8.00M | -10.19M | -14.09M | -15.13M |
| Investing Cash Flow | -209.29K | 0.00 | -3.23K | -14.11K | -102.70K | 0.00 |
| Financing Cash Flow | 5.86M | 5.10M | 7.54M | 6.15M | 14.05M | 18.93M |
Splash Beverage Group Technical Analysis
Neutral
0.73
Price Trends
0.49
Negative
0.80
Negative
1.97
Negative
Market Momentum
-0.02
Negative
48.92
Neutral
37.99
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SBEV, the sentiment is Neutral. The current price of 0.73 is above the 20-day moving average (MA) of 0.39, above the 50-day MA of 0.49, and below the 200-day MA of 1.97, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 48.92 is Neutral, neither overbought nor oversold. The STOCH value of 37.99 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SBEV.
Splash Beverage Group Risk Analysis
Splash Beverage Group disclosed 42 risk factors in its most recent earnings report. Splash Beverage Group reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Splash Beverage Group Peers Comparison
UnderperformOutperform
Sector (62)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | $2.36B | 20.78 | 6.96% | 2.49% | 0.56% | -28.00% | |
57 Neutral | $8.03B | -3.73 | -22.65% | 4.64% | -1.77% | -326.16% | |
55 Neutral | $1.95B | -27.90 | -8.89% | ― | -6.06% | -195.51% | |
43 Neutral | $3.02M | -0.02 | 592.71% | ― | -83.63% | 65.38% |
* Consumer Defensive Sector Average
SBEV
Splash Beverage Group
0.39
-6.58
-94.47%
SAM
Boston Beer
189.41
-32.56
-14.67%
CCU
Compania Cervecerias Unidas SA
12.56
0.48
4.00%
TAP
Molson Coors
42.01
-7.02
-14.31%
YHC
LQR House
1.66
-87.56
-98.14%
IBG
Innovation Beverage Group Ltd.
0.97
-14.28
-93.67%
Splash Beverage Group Corporate Events
Business Operations and StrategyDelistings and Listing Changes
Splash Beverage Rebrands as Endovia Health Sciences on NYSE
Positive
Aug 21, 2026
On August 21, 2026, Splash Beverage Group announced it will change its corporate name to Endovia Health Sciences, Inc., with its common stock set to begin trading on the NYSE American under the new ticker EDVA at the market open on Monday, August ...
Business Operations and StrategyDelistings and Listing Changes
Splash Beverage rebrands as Endovia Health Sciences company
Positive
Aug 12, 2026
On August 12, 2026, Splash Beverage Group announced it will rebrand as Endovia Health Sciences, Inc., with the change and new ticker symbol EDVA becoming effective August 24, 2026. The company will also launch a new corporate website and investor ...
Business Operations and StrategyRegulatory Filings and Compliance
Splash Beverage Rebrands as Endovia Health Sciences, Inc.
Neutral
Aug 11, 2026
On August 5, 2026, Splash Beverage Group, Inc. filed a Certificate of Amendment with the Nevada Secretary of State to change its corporate name, and on August 6, 2026, the company submitted a Certificate of Correction to address a scrivener’...
Business Operations and StrategyProduct-Related Announcements
Splash Beverage launches cannabinoid veterinary oncology collaboration
Positive
Aug 5, 2026
Splash Beverage Group, Inc., a NYSE American-listed company based in Fort Lauderdale, is pursuing a strategic shift toward a cannabinoid health, wellness and biopharmaceutical platform. The firm licenses CannEpil, a pharmaceutical-grade cannabidio...
Business Operations and StrategyPrivate Placements and Financing
Splash Beverage Group Enters Cannabinoid Veterinary Drug Partnership
Positive
Aug 4, 2026
On July 31, 2026, Splash Beverage Group entered into a Development and Collaboration Agreement with Lupvindol Biosciences to advance a new animal drug derived from its CannEpil® pharmaceutical product through U.S. FDA Center for Veterinary Me...
Business Operations and StrategyProduct-Related Announcements
Splash Beverage expands CannEpil into veterinary therapeutics
Positive
Jul 29, 2026
On July 28, 2026, Splash Beverage Group, Inc. and Argent BioPharma Limited amended their exclusive global license for the cannabinoid formulation CannEpil to expand its field of use into veterinary applications and adjust royalty terms. Under the ...
Business Operations and StrategyLegal Proceedings
Splash Beverage amends investor settlement payment agreements
Negative
Jul 21, 2026
On July 15, 2026, Splash Beverage Group amended settlement agreements with three investors concerning amounts they had invested in October 2024 under contracts they claimed the company had breached. The amendments shifted the timing and structure ...
Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Splash Beverage Group Announces One-for-Four Reverse Split
Negative
Jul 17, 2026
On July 16, 2026, Splash Beverage Group filed a Certificate of Change in Nevada to implement a one-for-four reverse stock split of its issued and outstanding common shares, effective at 4:30 p.m. Eastern Time on July 24, 2026, and to reduce author...
Business Operations and StrategyDelistings and Listing ChangesRegulatory Filings and ComplianceStock Split
Splash Beverage restructures capital to maintain NYSE listing
Positive
Jul 15, 2026
On July 14, 2026, Splash Beverage Group announced a series of balance sheet and capital structure moves as part of its NYSE American compliance plan. The company disclosed that it had negotiated settlements with multiple legacy creditors covering ...
Business Operations and StrategyPrivate Placements and Financing
Splash Beverage Group Reaches Debt-Reduction Settlement Agreement
Positive
Jul 13, 2026
On July 10, 2026, Splash Beverage Group, Inc. entered into a letter agreement with Decathlon Alpha IV, L.P., allowing the company to settle outstanding obligations of $2,834,689 under a 2020 revenue loan by making a single payment of $301,800.55 o...
Private Placements and FinancingRegulatory Filings and Compliance
Splash Beverage Group Raises Capital Through Equity Issuance
Neutral
Jul 10, 2026
From June 30, 2026 through July 8, 2026, Splash Beverage Group sold and issued 9,232,047 shares of common stock to C/M Capital Master Fund, LP under a previously disclosed September 19, 2025 Securities Purchase Agreement, generating gross proceeds...
Business Operations and StrategyDelistings and Listing ChangesPrivate Placements and FinancingRegulatory Filings and Compliance
Splash Beverage Gains NYSE Compliance Plan, Retains Listing
Positive
Jul 9, 2026
On July 8, 2026, Splash Beverage Group announced that NYSE American accepted its plan to regain compliance with the exchange’s shareholders’ equity and continued listing standards, granting the company a compliance period through Janua...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Splash Beverage inks CannEpil license, restructures capital
Positive
Jul 6, 2026
On July 6, 2026, Splash Beverage Group entered into an Exclusive License Agreement with Argent Biopharma to acquire worldwide rights to CannEpil, a proprietary liquid formulation of CBD and THC isolates for treatment and management of drug‑r...
Business Operations and StrategyPrivate Placements and Financing
Splash Beverage Secures Global CannEpil Licensing Agreement
Positive
Jul 6, 2026
On July 6, 2026, Splash Beverage Group announced an exclusive global licensing agreement with Argent BioPharma for CannEpil, a pharmaceutical-grade cannabinoid therapy for drug-resistant epilepsy already available in markets including Ireland, the...
Private Placements and FinancingRegulatory Filings and Compliance
Splash Beverage Raises Capital Through Equity Line Issuance
Neutral
Jun 26, 2026
On June 24, 2026, Splash Beverage Group sold and issued 767,953 shares of common stock to C/M Capital Master Fund, LP under a previously established equity line of credit agreement dated September 19, 2025, generating gross proceeds of $117,036. T...
Business Operations and StrategyPrivate Placements and Financing
Splash Beverage Makes Strategic Investment in Avicanna Inc.
Positive
Jun 15, 2026
On June 15, 2026, Splash Beverage Group announced it had completed a CDN$300,000 strategic investment in Avicanna Inc., a move that advances Splash’s transition into a cannabinoid health, wellness, and healthcare-focused platform company. Th...
Business Operations and StrategyExecutive/Board ChangesPrivate Placements and FinancingRegulatory Filings and Compliance
Splash Beverage advances cannabinoid strategy with Avicanna investment
Positive
Jun 12, 2026
On June 9, 2026, Splash Beverage Group invested about $217,000 to acquire 2,000,000 common shares and 1,000,000 warrants of Avicanna Inc., a commercial-stage cannabinoid biopharmaceutical firm, as part of its pivot toward a cannabinoid-based healt...
Business Operations and StrategyPrivate Placements and FinancingRegulatory Filings and Compliance
Splash Beverage Raises Capital via Structured Equity Sales
Neutral
Jun 4, 2026
From May 29, 2026 through June 1, 2026, Splash Beverage Group sold and issued 3,846,332 shares of common stock under a previously established Securities Purchase Agreement with C/M Capital Master Fund, LP, generating total gross proceeds of $607,7...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsRegulatory Filings and Compliance
Splash Beverage Updates NYSE Compliance, Explores Strategic Deals
Negative
Jun 3, 2026
On June 3, 2026, Splash Beverage Group issued a corporate update on its NYSE American compliance process, confirming it had received an April 29, 2026 notice that it was out of compliance with stockholders’ equity listing standards and submi...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.